HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies
CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 26,2025-- HBM Alpha Therapeutics (HBMAT),Inc.,an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142),announced a strateg